Digital speech-therapy app Zenicom for subacute post-stroke aphasia in Korean speakers
Official title: Evaluation of the Safety and Efficacy of the Digital Therapeutic Device Zenicom for Improving Aphasia in Patients With Subacute Stroke and Aphasia (AQ ≥25), a Multicenter, Single-blind, Prospective, Randomized Exploratory Clinical Trial
Run by Seoul National University Bundang Hospital · NCT07397923 · Data updated 2026-11-12
This trial will try the Zenicom digital speech-therapy app alongside conventional therapy to see if it helps Korean adults with aphasia after a recent (within 3 months) stroke.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Seoul National University Bundang Hospital Academic / other |
| Locations | 3 sites (Seongnam-si and 2 other locations) |
| Status | Recruiting |
| Started | December 10, 2025 |
| Main results expected | June 30, 2026 |
| Study ends | August 31, 2026 |
| Registry record updated | February 10, 2026 |
| Trial ID | NCT07397923 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥19 years) with a first-ever subacute stroke (within 3 months) who have aphasia confirmed by PK-WAB-R and are native Korean speakers able to read and consent.
✕Probably not a fit
Patients with progressive or hemodynamically unstable stroke, other neurological or major psychiatric disorders, severe visual impairment, illiteracy, or non‑Korean native speakers are unlikely to benefit from this device in this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, single-blind, randomized Phase 2 trial will enroll 20 adults with first-ever subacute stroke–related aphasia and randomize them 1:1 to conventional speech therapy alone or conventional therapy plus the Zenicom digital speech-therapy application. The experimental arm receives 30 minutes of conventional speech therapy daily plus an additional digital program during a 2-week treatment period, with language and safety outcomes followed during the overall 6-month trial period. Eligibility requires aphasia confirmed by the PK-WAB-R, Korean as the native language, and onset within 3 months of stroke, and excludes patients with progressive or unstable stroke or other major neuropsychiatric comorbidities. Primary endpoints focus on language function change and device safety to provide exploratory evidence of benefit and tolerability.
Why it matters
Potential benefit: If successful, Zenicom could speed or improve language recovery after subacute stroke and offer a scalable, language-tailored adjunct to conventional therapy.
How similar studies have gone: Other studies of computerized or tele-delivered speech therapy have shown modest benefits for post-stroke aphasia, but Zenicom is a language-specific digital therapeutic and remains exploratory in this population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 19 years or older. * Confirmed by a specialist to have aphasia caused by a stroke lesion. * First-ever subacute stroke (within 3 months of onset) diagnosed via radiological examination (CT, MRI). * Diagnosed with aphasia based on the Speech Assessment (PK-WAB-R). * Whose native language is Korean. Exclusion Criteria: * Have progressive or hemodynamically unstable stroke. * Having other neurological diseases suspected to affect language ability. * Co-morbid major psychiatric disorders requiring continuous medication (e.g., Major Depressive Disorder, Schizophrenia, Bipolar Disorder, Dementia). * Co-morbid major neurogenic diseases other than stroke. * Confirmed history of degenerative neuropathy. * Current or past substance or alcohol use disorder. * Visual impairment (Low vision severity: visual acuity of 0.1-0.3 or lower). * Intellectual disability. * Illiteracy (unable to read and consent).
Where it's running
-
Seoul National University Bundang Hospital
Seongnam-si, South Korea Recruiting -
Konkuk University Medical Center
Seoul, South Korea Recruiting -
Samsung Medical Center
Seoul, South Korea Recruiting
Study contacts
- Study coordinator: Pf. Won Kee Chang, MD, MS
- Email: wkchang@snubh.org
- Phone: +82-31-787-7737
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tailoring rTMS for Post-Stroke Aphasia Based on Language Profile
A non-drug brain stimulation approach is tested to see if customizing rTMS targets improves language recovery in people with aphasia after a left-brain stroke.
-
tDCS in Rehab for Stroke-Related Aphasia: A Practical Implementation
This study tests whether a 20-minute anodal tDCS session paired with speech therapy can be integrated into routine inpatient and outpatient rehab for people who recently had a stroke and now have aphasia.
-
Decoding Mandarin speech features from brain-surface signals
This project will try to decode imagined Mandarin speech, including lexical tones, from high-density brain-surface (ECoG) signals in adult patients who are having clinically indicated cortical electrode placement.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
TMS plus language therapy to improve word-finding after left-hemisphere stroke
Researchers will try excitatory transcranial magnetic stimulation combined with semantic feature analysis language therapy to improve word-finding in adults with aphasia after left-hemisphere stroke.
-
Using Transcranial Magnetic Stimulation and Language Therapy to Improve Speech After Stroke
This study is testing if combining a brain stimulation technique with speech therapy can help people who have had a stroke improve their speech during the early recovery phase.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.